Related references
Note: Only part of the references are listed.Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action
Richard A. Currie et al.
TOXICOLOGY (2014)
Low dose effects and non-monotonic dose responses for endocrine active chemicals: Science to practice workshop: Workshop summary
Claire Beausoleil et al.
CHEMOSPHERE (2013)
The adverse outcome pathway concept: A pragmatic tool in toxicology
Mathieu Vinken
TOXICOLOGY (2013)
Dose-response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides
Kei Tamura et al.
TOXICOLOGY LETTERS (2013)
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
Laura N. Vandenberg et al.
ENDOCRINE REVIEWS (2012)
Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: Has the case been made?
Lorenz R. Rhomberg et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2012)
Persistent developmental toxicity in rat offspring after low dose exposure to a mixture of endocrine disrupting pesticides
Pernille Rosenskjold Jacobsen et al.
REPRODUCTIVE TOXICOLOGY (2012)
The Hepatocarcinogenic Conazoles: Cyproconazole, Epoxiconazole, and Propiconazole Induce a Common Set of Toxicological and Transcriptional Responses
Susan Hester et al.
TOXICOLOGICAL SCIENCES (2012)
Conclusion on the peer review of the pesticide risk assessment of the active substance prochloraz European Food Safety Authority
EFSA JOURNAL (2011)
Reduction of Fusarium head blight and deoxynivalenol in wheat with early fungicide applications of prothioconazole
S. G. Edwards et al.
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT (2010)
Conclusion on the peer review of the pesticide risk assessment of the active substance cyproconazole
EFSA JOURNAL (2010)
Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A
John Peterson Myers et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
Inhibition of Rat and Human Steroidogenesis by Triazole Antifungals
Amber K. Goetz et al.
SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE (2009)
Discrimination of Tumorigenic Triazole Conazoles from Phenobarbital by Transcriptional Analyses of Mouse Liver Gene Expression
Stephen Nesnow et al.
TOXICOLOGICAL SCIENCES (2009)
Mode of Action for Reproductive and Hepatic Toxicity Inferred from a Genomic Study of Triazole Antifungals
Amber K. Goetz et al.
TOXICOLOGICAL SCIENCES (2009)
Toxicogenomic effects common to triazole antifungals and conserved between rats and humans
Amber K. Goetz et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
The biology of PGC-1α and its therapeutic potential
Christoph Handschin
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
IPCS framework for analyzing the relevance of a noncancer mode of action for humans
Alan R. Boobis et al.
CRITICAL REVIEWS IN TOXICOLOGY (2008)
Mouse liver effects of cyproconazole, a triazole fungicide: Role of the constitutive androstane receptor
Richard C. Peffer et al.
TOXICOLOGICAL SCIENCES (2007)
Induction of cytochrome P450 enzymes in rat liver by two conazoles, myclobutanil and triadimefon
G. Sun et al.
XENOBIOTICA (2007)
Comparison of lanosterol-14α-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles
Eva R. Troesken et al.
TOXICOLOGY (2006)
Gene expression profiling in liver and testis of rats to characterize the toxicity of triazole fungicides
Douglas B. Tully et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Gene expression profiling in the liver of CD-1 mice to characterize the hepatotoxicity of triazole fungicides
Amber K. Goetz et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Postulated pathogenic pathway in triazole fungicide induced dysmorphogenic effects
Elena Menegola et al.
REPRODUCTIVE TOXICOLOGY (2006)
Transcriptional profiles in liver from mice treated with hepatotumorigenic and nonhepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil
William O. Ward et al.
TOXICOLOGIC PATHOLOGY (2006)
Toxicity profiles in rats treated with tumorigenic and nontumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil
Douglas C. Wolf et al.
TOXICOLOGIC PATHOLOGY (2006)
Transcriptional profiles in liver from rats treated with tumorigenic and non-tumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil
Susan D. Hester et al.
TOXICOLOGIC PATHOLOGY (2006)
PGC-1α deficiency causes multi-system energy metabolic derangements:: Muscle dysfunction, abnormal weight control and hepatic steatosis
TC Leone et al.
PLOS BIOLOGY (2005)
Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver
GB Sun et al.
TOXICOLOGY LETTERS (2005)
Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans
ER Trosken et al.
ENDOCRINE RESEARCH (2004)
Effects of currently used pesticides in the AhR-CALUX assay: comparison between the human TV101L and the rat H4IIE cell line
M Long et al.
TOXICOLOGY (2003)
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14α-demethylase and aromatase
JA Zarn et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Share Paper
